Login prior to clicking the links below
| Welcome Address Samantha Gray, Robyn Macfarlane, Lori Wood |
VIEW |
| Keynote Lecture - Papillary Renal Cell Cancer: Where are we in 2018? Monty Pal |
VIEW |
| Determining Biomarkers Of Response to Docetaxel For Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Using Circulating Cell-Free Tumor DNA (ctDNA) Daniel Khalaf |
VIEW |
| Keynote Lecture - Update on Renal Cell Carcinoma Genomics Monty Pal |
VIEW |
| Untreated Advanced Clear Cell Renal Cell Carcinoma: State of The Art and Future Options Presenter and Faciliator: Aly-Khan Lalani |
VIEW |
| Molecular Markers To Predict Response To Neoadjuvant Chemotherapy in Urothelial Cancer Peter Black |
VIEW |
| Contemporary Management of M0 Prostate Cancer Michael Kolinsky |
VIEW |
| ASCO Updates Shaan Dudani |
VIEW |
Canadian Research in Genitourinary Oncology |
|
Astellas Awards: 2018 Winners and Presentations by Past WinnersFacilitated by Srikala Sridhar |
VIEW |
| I. Predictive RadiOMics SiganturE for Treatment Response To Nivolumab Or PD-1/PD-L1 Inhibitors in Patients With Advanced Renal Cell Carcinomas (PROMISE) Hao-Wen Sim |
VIEW |
| II. The Germline Genetics of Prostate Cancer: Caring for Patients with Hereditary Prostate Cancer and their Families Steve Yip |
VIEW |
| III. Characterization of Micro-RNA as Tumour Biomarkers in Patient With Germ Cell Testicular Cancer Lucia Nappi |
VIEW |
| 1515 – 1605 Update on CCTG Trials Facilitated by Kim Chi |
VIEW |
| Prostate – Kim Chi | VIEW |
| Bladder – Srikala Sridhar | VIEW |
| Kidney – Daniel Heng | VIEW |
| A Blood Derived Extracellular Vesicle Fingerprint to Predict the Presence of Clinically Significant Carcinoma of the Prostate -Peter Venner | VIEW |
| Case Conference Naveen Basappa |
VIEW |
| Case Conference Aly-Khan Lalani |
VIEW |
| Case Conference Joanna Virgidis |
VIEW |
| Case Conference Michael Kolinsky |
VIEW |
| Case Conference Scott North |
VIEW |
| Closing Remarks Dean Ruether |
VIEW |